Company Filing History:
Years Active: 2013-2014
Title: Sannah Zoffmann Jensen: Innovator in Pharmaceutical Sciences
Introduction
Sannah Zoffmann Jensen is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for medical applications. With a total of 3 patents to her name, her work focuses on addressing critical health issues.
Latest Patents
Among her latest patents is the invention related to Heteroarylmethyl amides. This invention pertains to compounds that are designed to be used as medicaments for the treatment and/or prophylaxis of diseases that can be treated with HDL-cholesterol raising agents. These include conditions such as dyslipidemia, atherosclerosis, and cardiovascular diseases. Another notable patent is the Tmem27 antibody, which is directed to a beta cell marker protein, specifically targeting the protein TMEM27.
Career Highlights
Sannah has worked with renowned companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Genentech, Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field.
Collaborations
Throughout her career, Sannah has collaborated with esteemed colleagues such as Hugues Matile and Paul Hebeisen. These partnerships have further enhanced her innovative work and expanded her impact in the industry.
Conclusion
Sannah Zoffmann Jensen is a trailblazer in pharmaceutical innovation, with a focus on developing effective treatments for serious health conditions. Her contributions continue to shape the future of medicine and improve patient outcomes.